Comprehensive Snapshot for Vaginal Antifungals Market Including Regional and Country Analysis in Brief.
Industry: Healthcare
Delivery Timelines: Please Contact Sales
Published Date: May-2025
Format: PPT*, PDF, EXCEL
Number of Pages: 250
ID: PMRREP33292
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Key Innovation / Development Trends
4. Key Success Factors
4.1. Promotional Strategies, By Key Manufacturers
4.2. Key Regulations
4.3. Reimbursement Scenario
4.4. Pipeline Analysis
4.5. Value Chain Analysis
4.6. PESTEL Analysis
4.7. Porter’s Analysis
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global GDP Growth Outlook
5.1.2. Global Healthcare Expenditure Outlook
5.1.3. Global Antifungal Drugs Market Outlook
5.2. Forecast Factors - Relevance & Impact
5.2.1. Impact of the COVID-19 Pandemic
5.2.2. Increasing Product Launch Activities
5.2.3. Prevalence of Vaginal Fungal Infections in HRT Patients
5.2.4. High Rates of Vulvovaginal Candidiasis
5.2.5. Impact on Quality-of-Life
5.2.6. Increasing Number of People with Predisposing Conditions Such as Diabetes Treated with SGLT2 Inhibitors
5.2.7. Growing Problems of Azole Resistance
5.2.8. Toxicity of Antifungal Drugs
5.3. Market Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity Analysis
6. COVID-19 Crisis Analysis
6.1. COVID-19 and Impact Analysis
6.1.1. By Drug
6.1.2. By Route of Administration
6.1.3. By Distribution Channel
6.1.4. By Country
6.2. 2021 Market Scenario
7. Global Vaginal Antifungals Market Demand (in Value or Size in US$ Mn) Analysis 2019-2032
7.1. Historical Market Value (US$ Mn) Analysis, 2019-2024
7.2. Current and Future Market Value (US$ Mn) Projections, 2025-2032
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis
8. Global Vaginal Antifungals Market Analysis 2019-2032, By Drug
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Mn) Analysis By Drug, 2019-2024
8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Drug, 2025-2032
8.3.1. Fluconazole
8.3.2. Nystatin
8.3.3. Flucytosine
8.3.4. Clotrimazole
8.3.5. Ketoconazole
8.3.6. Terbinafine
8.3.7. Others
8.4. Market Attractiveness Analysis By Drug
9. Global Vaginal Antifungals Market Analysis 2019-2032, By Route of Administration
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) Analysis By Route of Administration, 2019-2024
9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Route of Administration, 2025-2032
9.3.1. Oral
9.3.2. Topical
9.4. Market Attractiveness Analysis By Route of Administration
10. Global Vaginal Antifungals Market Analysis 2019-2032, By Distribution Channel
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2019-2024
10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Distribution Channel, 2025-2032
10.3.1. Hospital Pharmacies
10.3.2. Retail Pharmacies
10.3.3. Online Pharmacies
10.4. Market Attractiveness Analysis By Distribution Channel
11. Global Vaginal Antifungals Market Analysis 2019-2032, By Region
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Mn) Analysis By Region, 2019-2024
11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Region, 2025-2032
11.3.1. North America
11.3.2. Latin America
11.3.3. Europe
11.3.4. East Asia
11.3.5. South Asia
11.3.6. Oceania
11.3.7. Middle East and Africa
11.4. Market Attractiveness Analysis By Region
12. North America Vaginal Antifungals Market Analysis 2019-2032
12.1. Introduction
12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2024
12.3. Current and Future Market Size (US$ Mn) Analysis & Forecast By Market Taxonomy, 2025-2032
12.3.1. By Country
12.3.1.1. U.S.
12.3.1.2. Canada
12.3.2. By Drug
12.3.3. By Route of Administration
12.3.4. By Distribution Channel
12.4. Market Attractiveness Analysis
12.4.1. By Country
12.4.2. By Drug
12.4.3. By Route of Administration
12.4.4. By Distribution Channel
12.5. Market Trends
12.6. Key Market Participants - Intensity Mapping
12.7. Drivers and Restraints - Impact Analysis
12.8. Country Level Analysis & Forecast
12.8.1. U.S. Vaginal Antifungals Market Analysis
12.8.1.1. Introduction
12.8.1.2. Market Analysis and Forecast By Market Taxonomy
12.8.1.2.1. By Drug
12.8.1.2.2. By Route of Administration
12.8.1.2.3. By Distribution Channel
12.8.2. Canada Vaginal Antifungals Market Analysis
12.8.2.1. Introduction
12.8.2.2. Market Analysis and Forecast By Market Taxonomy
12.8.2.2.1. By Drug
12.8.2.2.2. By Route of Administration
12.8.2.2.3. By Distribution Channel
13. Latin America Vaginal Antifungals Market Analysis 2019-2032
13.1. Introduction
13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2024
13.3. Current and Future Market Size (US$ Mn) Analysis & Forecast By Market Taxonomy, 2025-2032
13.3.1. By Country
13.3.1.1. Mexico
13.3.1.2. Brazil
13.3.1.3. Argentina
13.3.1.4. Rest of Latin America
13.3.1.4.1. By Country
13.3.1.4.2. By Drug
13.3.1.4.3. By Route of Administration
13.3.1.4.4. By Distribution Channel
13.4. Market Attractiveness Analysis
13.4.1. By Country
13.4.2. By Drug
13.4.3. By Route of Administration
13.4.4. By Distribution Channel
13.5. Market Trends
13.6. Key Market Participants - Intensity Mapping
13.7. Drivers and Restraints - Impact Analysis
13.8. Country Level Analysis & Forecast
13.8.1. Mexico Vaginal Antifungals Market Analysis
13.8.1.1. Introduction
13.8.1.2. Market Analysis and Forecast By Market Taxonomy
13.8.1.2.1. By Drug
13.8.1.2.2. By Route of Administration
13.8.1.2.3. By Distribution Channel
13.8.2. Brazil Vaginal Antifungals Market Analysis
13.8.2.1. Introduction
13.8.2.2. Market Analysis and Forecast By Market Taxonomy
13.8.2.2.1. By Country
13.8.2.2.2. By Drug
13.8.2.2.3. By Route of Administration
13.8.2.2.4. By Distribution Channel
13.8.3. Argentina Vaginal Antifungals Market Analysis
13.8.3.1. Introduction
13.8.3.2. Market Analysis and Forecast By Market Taxonomy
13.8.3.2.1. By Drug
13.8.3.2.2. By Route of Administration
13.8.3.2.3. By Distribution Channel
14. Europe Vaginal Antifungals Market Analysis 2019-2032
14.1. Introduction
14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2024
14.3. Current and Future Market Size (US$ Mn) Analysis & Forecast By Market Taxonomy, 2025-2032
14.3.1. By Country
14.3.1.1. Germany
14.3.1.2. Italy
14.3.1.3. France
14.3.1.4. U.K.
14.3.1.5. Spain
14.3.1.6. BENELUX
14.3.1.7. Russia
14.3.1.8. Rest of Europe
14.3.2. By Drug
14.3.3. By Route of Administration
14.3.4. By Distribution Channel
14.4. Market Attractiveness Analysis
14.4.1. By Country
14.4.2. By Drug
14.4.3. By Route of Administration
14.4.4. By Distribution Channel
14.5. Market Trends
14.6. Key Market Participants - Intensity Mapping
14.7. Drivers and Restraints - Impact Analysis
14.8. Country Level Analysis & Forecast
14.8.1. Germany Vaginal Antifungals Market Analysis
14.8.1.1. Introduction
14.8.1.2. Market Analysis and Forecast By Market Taxonomy
14.8.1.2.1. By Drug
14.8.1.2.2. By Route of Administration
14.8.1.2.3. By Distribution Channel
14.8.2. Italy Vaginal Antifungals Market Analysis
14.8.2.1. Introduction
14.8.2.2. Market Analysis and Forecast By Market Taxonomy
14.8.2.2.1. By Drug
14.8.2.2.2. By Route of Administration
14.8.2.2.3. By Distribution Channel
14.8.3. France Vaginal Antifungals Market Analysis
14.8.3.1. Introduction
14.8.3.2. Market Analysis and Forecast By Market Taxonomy
14.8.3.2.1. By Drug
14.8.3.2.2. By Route of Administration
14.8.3.2.3. By Distribution Channel
14.8.4. U.K. Vaginal Antifungals Market Analysis
14.8.4.1. Introduction
14.8.4.2. Market Analysis and Forecast By Market Taxonomy
14.8.4.2.1. By Drug
14.8.4.2.2. By Route of Administration
14.8.4.2.3. By Distribution Channel
14.8.5. Spain Vaginal Antifungals Market Analysis
14.8.5.1. Introduction
14.8.5.2. Market Analysis and Forecast By Market Taxonomy
14.8.5.2.1. By Drug
14.8.5.2.2. By Route of Administration
14.8.5.2.3. By Distribution Channel
14.8.6. BENELUX Vaginal Antifungals Market Analysis
14.8.6.1. Introduction
14.8.6.2. Market Analysis and Forecast By Market Taxonomy
14.8.6.2.1. By Drug
14.8.6.2.2. By Route of Administration
14.8.6.2.3. By Distribution Channel
14.8.7. Russia Vaginal Antifungals Market Analysis
14.8.7.1. Introduction
14.8.7.2. Market Analysis and Forecast By Market Taxonomy
14.8.7.2.1. By Drug
14.8.7.2.2. By Route of Administration
14.8.7.2.3. By Distribution Channel
15. East Asia Vaginal Antifungals Market Analysis 2019-2032
15.1. Introduction
15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2024
15.3. Current and Future Market Size (US$ Mn) Analysis & Forecast By Market Taxonomy, 2025-2032
15.3.1. By Country
15.3.1.1. China
15.3.1.2. Japan
15.3.1.3. South Korea
15.3.2. By Drug
15.3.3. By Route of Administration
15.3.4. By Distribution Channel
15.4. Market Attractiveness Analysis
15.4.1. By Country
15.4.2. By Drug
15.4.3. By Route of Administration
15.4.4. By Distribution Channel
15.5. Market Trends
15.6. Key Market Participants - Intensity Mapping
15.7. Drivers and Restraints - Impact Analysis
15.8. Country Level Analysis & Forecast
15.8.1. China Vaginal Antifungals Market Analysis
15.8.1.1. Introduction
15.8.1.2. Market Analysis and Forecast By Market Taxonomy
15.8.1.2.1. By Drug
15.8.1.2.2. By Route of Administration
15.8.1.2.3. By Distribution Channel
15.8.2. Japan Vaginal Antifungals Market Analysis
15.8.2.1. Introduction
15.8.2.2. Market Analysis and Forecast By Market Taxonomy
15.8.2.2.1. By Drug
15.8.2.2.2. By Route of Administration
15.8.2.2.3. By Distribution Channel
15.8.3. South Korea Vaginal Antifungals Market Analysis
15.8.3.1. Introduction
15.8.3.2. Market Analysis and Forecast By Market Taxonomy
15.8.3.2.1. By Drug
15.8.3.2.2. By Route of Administration
15.8.3.2.3. By Distribution Channel
16. South Asia Vaginal Antifungals Market Analysis 2019-2032
16.1. Introduction
16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2024
16.3. Current and Future Market Size (US$ Mn) Analysis & Forecast By Market Taxonomy, 2025-2032
16.3.1. By Country
16.3.1.1. India
16.3.1.2. Indonesia
16.3.1.3. Malaysia
16.3.1.4. Thailand
16.3.1.5. Rest of South Asia
16.3.2. By Drug
16.3.3. By Route of Administration
16.3.4. By Distribution Channel
16.4. Market Attractiveness Analysis
16.4.1. By Country
16.4.2. By Drug
16.4.3. By Route of Administration
16.4.4. By Distribution Channel
16.5. Market Trends
16.6. Key Market Participants - Intensity Mapping
16.7. Drivers and Restraints - Impact Analysis
16.8. Country Level Analysis & Forecast
16.8.1. India Vaginal Antifungals Market Analysis
16.8.1.1. Introduction
16.8.1.2. Market Analysis and Forecast By Market Taxonomy
16.8.1.2.1. By Drug
16.8.1.2.2. By Route of Administration
16.8.1.2.3. By Distribution Channel
16.8.2. Indonesia Vaginal Antifungals Market Analysis
16.8.2.1. Introduction
16.8.2.2. Market Analysis and Forecast By Market Taxonomy
16.8.2.2.1. By Drug
16.8.2.2.2. By Route of Administration
16.8.2.2.3. By Distribution Channel
16.8.3. Malaysia Vaginal Antifungals Market Analysis
16.8.3.1. Introduction
16.8.3.2. Market Analysis and Forecast By Market Taxonomy
16.8.3.2.1. By Drug
16.8.3.2.2. By Route of Administration
16.8.3.2.3. By Distribution Channel
16.8.4. Thailand Vaginal Antifungals Market Analysis
16.8.4.1. Introduction
16.8.4.2. Market Analysis and Forecast By Market Taxonomy
16.8.4.2.1. By Drug
16.8.4.2.2. By Route of Administration
16.8.4.2.3. By Distribution Channel
17. Oceania Vaginal Antifungals Market 2019-2032
17.1. Introduction
17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2024
17.3. Current and Future Market Size (US$ Mn) Analysis & Forecast By Market Taxonomy, 2025-2032
17.3.1. By Country
17.3.1.1. Australia
17.3.1.2. New Zealand
17.3.2. By Drug
17.3.3. By Route of Administration
17.3.4. By Distribution Channel
17.4. Market Attractiveness Analysis
17.4.1. By Country
17.4.2. By Drug
17.4.3. By Route of Administration
17.4.4. By Distribution Channel
17.5. Key Market Participants - Intensity Mapping
17.6. Drivers and Restraints - Impact Analysis
17.7. Country Level Analysis & Forecast
17.7.1. Australia Vaginal Antifungals Market Analysis
17.7.1.1. Introduction
17.7.1.2. Market Analysis and Forecast By Market Taxonomy
17.7.1.2.1. By Drug
17.7.1.2.2. By Route of Administration
17.7.1.2.3. By Distribution Channel
17.7.2. New Zealand Vaginal Antifungals Market Analysis
17.7.2.1. Introduction
17.7.2.2. Market Analysis and Forecast By Market Taxonomy
17.7.2.2.1. By Drug
17.7.2.2.2. By Route of Administration
17.7.2.2.3. By Distribution Channel
18. Middle East and Africa (MEA) Vaginal Antifungals Market Analysis 2019-2032
18.1. Introduction
18.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2024
18.3. Current and Future Market Size (US$ Mn) Analysis & Forecast By Market Taxonomy, 2025-2032
18.3.1. By Country
18.3.1.1. GCC Countries
18.3.1.2. Türkiye
18.3.1.3. South Africa
18.3.1.4. North Africa
18.3.1.5. Rest of Middle East and Africa
18.3.2. By Drug
18.3.3. By Route of Administration
18.3.4. By Distribution Channel
18.4. Market Attractiveness Analysis
18.4.1. By Country
18.4.2. By Drug
18.4.3. By Route of Administration
18.4.4. By Distribution Channel
18.5. Market Trends
18.6. Key Market Participants - Intensity Mapping
18.7. Drivers and Restraints - Impact Analysis
18.8. Country Level Analysis & Forecast
18.8.1. GCC Countries Vaginal Antifungals Market Analysis
18.8.1.1. Introduction
18.8.1.2. Market Analysis and Forecast By Market Taxonomy
18.8.1.2.1. By Drug
18.8.1.2.2. By Route of Administration
18.8.1.2.3. By Distribution Channel
18.8.2. Türkiye Vaginal Antifungals Market Analysis
18.8.2.1. Introduction
18.8.2.2. Market Analysis and Forecast By Market Taxonomy
18.8.2.2.1. By Drug
18.8.2.2.2. By Route of Administration
18.8.2.2.3. By Distribution Channel
18.8.3. South Africa Vaginal Antifungals Market Analysis
18.8.3.1. Introduction
18.8.3.2. Market Analysis and Forecast By Market Taxonomy
18.8.3.2.1. By Drug
18.8.3.2.2. By Route of Administration
18.8.3.2.3. By Distribution Channel
18.8.4. North Africa Vaginal Antifungals Market Analysis
18.8.4.1. Introduction
18.8.4.2. Market Analysis and Forecast By Market Taxonomy
18.8.4.2.1. By Drug
18.8.4.2.2. By Route of Administration
18.8.4.2.3. By Distribution Channel
19. Market Structure Analysis
19.1. Market Analysis By Tier of Companies
19.2. Market Concentration
19.3. Market Share Analysis of Top Players
19.4. Market Presence Analysis
20. Competition Analysis
20.1. Competition Dashboard
20.2. Competition Benchmarking
20.3. Competition Deep Dive
20.3.1. Pfizer Inc.
20.3.1.1. Overview
20.3.1.2. Product Portfolio
20.3.1.3. Sales Footprint
20.3.1.4. Key Financials
20.3.1.5. SWOT Analysis
20.3.1.6. Strategic Overview
20.3.2. Bausch Health Companies Inc
20.3.2.1. Overview
20.3.2.2. Product Portfolio
20.3.2.3. Sales Footprint
20.3.2.4. Key Financials
20.3.2.5. SWOT Analysis
20.3.2.6. Strategic Overview
20.3.3. ANI Pharmaceuticals, Inc.
20.3.3.1. Overview
20.3.3.2. Product Portfolio
20.3.3.3. Sales Footprint
20.3.3.4. Key Financials
20.3.3.5. SWOT Analysis
20.3.3.6. Strategic Overview
20.3.4. Hikma Pharmaceuticals Plc
20.3.4.1. Overview
20.3.4.2. Product Portfolio
20.3.4.3. Sales Footprint
20.3.4.4. Key Financials
20.3.4.5. SWOT Analysis
20.3.4.6. Strategic Overview
20.3.5. Lupin Limited
20.3.5.1. Overview
20.3.5.2. Product Portfolio
20.3.5.3. Sales Footprint
20.3.5.4. Key Financials
20.3.5.5. SWOT Analysis
20.3.5.6. Strategic Overview
20.3.6. Mycovia Pharmaceuticals, Inc.
20.3.6.1. Overview
20.3.6.2. Product Portfolio
20.3.6.3. Sales Footprint
20.3.6.4. Key Financials
20.3.6.5. SWOT Analysis
20.3.6.6. Strategic Overview
20.3.7. Glenmark Pharmaceuticals Limited
20.3.7.1. Overview
20.3.7.2. Product Portfolio
20.3.7.3. Sales Footprint
20.3.7.4. Key Financials
20.3.7.5. SWOT Analysis
20.3.7.6. Strategic Overview
20.3.8. Unique Pharmaceuticals
20.3.8.1. Overview
20.3.8.2. Product Portfolio
20.3.8.3. Sales Footprint
20.3.8.4. Key Financials
20.3.8.5. SWOT Analysis
20.3.8.6. Strategic Overview
20.3.9. PEPTONIC medical AB
20.3.9.1. Overview
20.3.9.2. Product Portfolio
20.3.9.3. Sales Footprint
20.3.9.4. Key Financials
20.3.9.5. SWOT Analysis
20.3.9.6. Strategic Overview
20.3.10. Aurobindo Pharma Limited
20.3.10.1. Overview
20.3.10.2. Product Portfolio
20.3.10.3. Sales Footprint
20.3.10.4. Key Financials
20.3.10.5. SWOT Analysis
20.3.10.6. Strategic Overview
20.3.11. Dr. Reddy's Laboratories
20.3.11.1. Overview
20.3.11.2. Product Portfolio
20.3.11.3. Sales Footprint
20.3.11.4. Key Financials
20.3.11.5. SWOT Analysis
20.3.11.6. Strategic Overview
20.3.12. SCYNEXIS, Inc.
20.3.12.1. Overview
20.3.12.2. Product Portfolio
20.3.12.3. Sales Footprint
20.3.12.4. Key Financials
20.3.12.5. SWOT Analysis
20.3.12.6. Strategic Overview
20.3.13. Basilea Pharmaceutica Ltd.
20.3.13.1. Overview
20.3.13.2. Product Portfolio
20.3.13.3. Sales Footprint
20.3.13.4. Key Financials
20.3.13.5. SWOT Analysis
20.3.13.6. Strategic Overview
20.3.14. Astellas Pharma Inc.
20.3.14.1. Overview
20.3.14.2. Product Portfolio
20.3.14.3. Sales Footprint
20.3.14.4. Key Financials
20.3.14.5. SWOT Analysis
20.3.14.6. Strategic Overview
20.3.15. Grupo Ferrer Internacional, S.A.
20.3.15.1. Overview
20.3.15.2. Product Portfolio
20.3.15.3. Sales Footprint
20.3.15.4. Key Financials
20.3.15.5. SWOT Analysis
20.3.15.6. Strategic Overview
20.3.16. Pacgen Life Science Corporation
20.3.16.1. Overview
20.3.16.2. Product Portfolio
20.3.16.3. Sales Footprint
20.3.16.4. Key Financials
20.3.16.5. SWOT Analysis
20.3.16.6. Strategic Overview
20.3.17. NovaDigm Therapeutics, Inc.
20.3.17.1. Overview
20.3.17.2. Product Portfolio
20.3.17.3. Sales Footprint
20.3.17.4. Key Financials
20.3.17.5. SWOT Analysis
20.3.17.6. Strategic Overview
20.3.18. Cidara Therapeutics, Inc.
20.3.18.1. Overview
20.3.18.2. Product Portfolio
20.3.18.3. Sales Footprint
20.3.18.4. Key Financials
20.3.18.5. SWOT Analysis
20.3.18.6. Strategic Overview
20.3.19. Amplyx Pharmaceuticals Inc.
20.3.19.1. Overview
20.3.19.2. Product Portfolio
20.3.19.3. Sales Footprint
20.3.19.4. Key Financials
20.3.19.5. SWOT Analysis
20.3.19.6. Strategic Overview
21. Assumptions and Acronyms Used
22. Research Methodology
